Confluence Pharmaceuticals
Indianapolis
About Confluence Pharmaceuticals
Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders. The company's current focus is advancing a novel drug discovery that improves social and communication impairments for individuals with Autism Spectrum Disorders and Fragile X Syndrome.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.0M
- Last round: Series Unknown (Jun 2022)
- Website: confluencepharma.com
- Phone: +113173797498
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/confluence-pharmaceuticals-22659 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.